A detailed history of State Of Wisconsin Investment Board transactions in Abb Vie Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 1,038,060 shares of ABBV stock, worth $178 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
1,038,060
Previous 971,360 6.87%
Holding current value
$178 Million
Previous $151 Million 25.58%
% of portfolio
0.52%
Previous 0.44%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $10.7 Million - $12.1 Million
66,700 Added 6.87%
1,038,060 $189 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $2.04 Million - $2.29 Million
14,808 Added 1.55%
971,360 $151 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $2.87 Million - $3.32 Million
-21,466 Reduced 2.19%
956,552 $143 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $2.41 Million - $3 Million
-18,183 Reduced 1.83%
978,018 $132 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $13.6 Million - $15.7 Million
94,338 Added 10.46%
996,201 $159 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $14.1 Million - $16.9 Million
-102,183 Reduced 10.18%
901,863 $146 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $33.4 Million - $38.3 Million
-248,654 Reduced 19.85%
1,004,046 $135 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $11.5 Million - $14.7 Million
-83,907 Reduced 6.28%
1,252,700 $192 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $7.64 Million - $9.48 Million
-57,893 Reduced 4.15%
1,336,607 $217 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $25.8 Million - $32.6 Million
239,986 Added 20.79%
1,394,500 $189 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $63.1 Million - $71.6 Million
-593,205 Reduced 33.94%
1,154,514 $125 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $8.62 Million - $9.6 Million
-81,906 Reduced 4.48%
1,747,719 $197 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $8.96 Million - $9.86 Million
87,541 Added 5.03%
1,829,625 $198 Million
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $8.07 Million - $10.9 Million
-100,301 Reduced 5.44%
1,742,084 $187 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $14.5 Million - $17 Million
-168,976 Reduced 8.4%
1,842,385 $161 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $38 Million - $50.8 Million
517,552 Added 34.65%
2,011,361 $178 Million
Q1 2020

May 06, 2020

SELL
$64.5 - $97.79 $7.7 Million - $11.7 Million
-119,353 Reduced 7.4%
1,493,809 $114 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $24.1 Million - $30.1 Million
333,631 Added 26.07%
1,613,162 $143 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $14.3 Million - $17.1 Million
-226,309 Reduced 15.03%
1,279,531 $96.9 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $9.06 Million - $11.6 Million
137,831 Added 10.08%
1,505,840 $110 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $12 Million - $14.1 Million
-155,610 Reduced 10.21%
1,368,009 $110 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $10.1 Million - $12.4 Million
-129,445 Reduced 7.83%
1,523,619 $140 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $5.14 Million - $5.72 Million
-57,859 Reduced 3.38%
1,653,064 $156 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $8.05 Million - $9.52 Million
-89,661 Reduced 4.98%
1,710,923 $159 Million
Q1 2018

May 07, 2018

BUY
$92.01 - $123.21 $8.07 Million - $10.8 Million
87,663 Added 5.12%
1,800,584 $170 Million
Q4 2017

Feb 08, 2018

BUY
$89.56 - $98.21 $7.98 Million - $8.76 Million
89,155 Added 5.49%
1,712,921 $166 Million
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $113 Million - $145 Million
1,623,766
1,623,766 $144 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.